BILL ANALYSIS Ó
AB 2325
Page 1
Date of Hearing: April 27, 2016
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
AB
2325 (Bonilla) - As Amended April 5, 2016
-----------------------------------------------------------------
|Policy |Health |Vote:|16 - 0 |
|Committee: | | | |
| | | | |
| | | | |
-----------------------------------------------------------------
Urgency: No State Mandated Local Program: NoReimbursable: No
SUMMARY:
This bill requires, on or after January 1, 2019, a pathologist
diagnosing cancer to report cancer diagnoses to the California
Cancer Registry (CCR) of the California Department of Public
Health (CDPH) in a format prescribed by CDPH, and establishes a
pilot project to enable CDPH and authorized users to conduct
electronic specific data element searches of the information
collected by the registry.
FISCAL EFFECT:
AB 2325
Page 2
As the business model of the CCR already incorporates a move to
standardized electronic reporting and the CCR already has the
technical capacity to conduct electronic data searches, costs
are expected to be minor and absorbable (Proposition 99 funds).
COMMENTS:
1)Purpose. This bill will allow the CCR to be used by
researchers in order to find patients who may benefit from
clinical trials, and will make reporting to the registry more
rapid by requiring electronic reporting by pathologists who
diagnose cancer. This bill is co-sponsored by the American
Cancer Society Action Network and the University of Southern
California.
2)Background. The CCR is a statewide, population-based cancer
surveillance system that monitors the incidence of mortality
of specific cancer over time, and analyzes differential risks
of cancer by race/ethnicity, age, sex, geographic region, and
other social characteristics of the population. The CCR
conducts research and collaborates with researchers on cancer
research projects related to treatment, risk factors, and
prevention of cancer. This bill is expected to modernize and
improve the utility of the CCR.
3)Related Legislation. AB 1823 (Bonilla), also being heard
today, requests the UC to establish a grant program to
increase participation in clinical trials, as specified.
Analysis Prepared by:Lisa Murawski / APPR. / (916)
319-2081
AB 2325
Page 3